Little Rock

The trials here

What the 4 trials at this site are about, from their registry records.

Conditions

• Epilepsy2 trials
• Crohn's disease1 trial
• High blood pressure1 trial

Phase

• Phase 32 trials
• Phase 21 trial
• Phase 41 trial

Status

• Active, not recruiting1 trial
• Not yet recruiting1 trial
• Recruiting1 trial
• Terminated1 trial

Lead sponsor

• Jazz Pharmaceuticals2 trials
• Alnylam Pharmaceuticals1 trial
• Shattuck Labs, Inc.1 trial

Running trials

• Recruiting

  A Study of SL-325 in Crohn's Disease Patients

  NCT07753850· Phase 2· Shattuck Labs, Inc.· Source

  Contact: Shattuck Medical Director

• Recruiting

  Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease

  NCT07181109· Phase 3· Alnylam Pharmaceuticals· Source

• Active, not recruiting

  Assessment of Potential for Chronic Liver Injury in Participants Treated With Epidiolex (Cannabidiol) Oral Solution

  NCT05044819· Phase 4· Jazz Pharmaceuticals· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Crohn's disease1 recruiting
• High blood pressure1 recruiting

Closed trials

• Terminated

  Assessment of Adjunctive Cannabidiol Oral Solution (GWP42003-P) in Children With Tuberous Sclerosis Complex (TSC), Dravet Syndrome (DS), or Lennox-Gastaut Syndrome (LGS) Who Experience Inadequately-controlled Seizures

  NCT04485104· Phase 3· Jazz Pharmaceuticals· Source